Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure

Article provides background on use of SGLT2i in patients with heart failure, reviews evidence for their use, suggests how they may be implemented in clinical practice as a new cornerstone in management of this population, and discusses ongoing trials.

Heart